Serum 25‐hydroxyvitamin D3 is related to physical activity and ethnicity but not obesity in a multicultural workforce
- 1 June 1995
- journal article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 25 (3), 218-223
- https://doi.org/10.1111/j.1445-5994.1995.tb01526.x
Abstract
Methods: Serum 25‐hydroxyvitamin D3, a marker of recent sun exposure and vitamin D status, was measured in 390 New Zealand residents (95 Pacific Islanders, 74 Maori and 221 others mostly of European descent), who were part of a larger cross‐sectional survey of a workforce (n= 5677) aged 40–64 years. Results: Serum 25‐hydroxyvitamin D3 levels were significantly lower in Pacific Islanders (mean (SE) = 56 (3) nmol/L; p= 0.0001) and Maoris (68 (3) nmol/L; p=0.036) compared with Europeans (75 (2) nmol/L) after adjusting for age, sex and time of year. Also adjusting for ethnic group, 25‐hydroxyvitamin D, was higher in people doing vigorous (aerobic) leisure physical activities (71 (2) nmol/L; p=0.0066) and moderate (non‐aerobic) activities (68 (3) nmol/L; p = 0.12) compared with those who were inactive (63 (2) nmol/L). However, 25‐hydroxyvitamin D3 was unrelated to body mass index, serum lipids, blood pressure or cigarette smoking. Background: Recent research suggests that body vitamin D levels are decreased in coronary heart disease and diabetes, but it is unclear which cardiovascular risk factors are related to vitamin D status. Aims: To examine the relation between vitamin D status and major cardiovascular risk factors. Conclusions: People with increased skin pigmentation, such as Polynesians, and people who are inactive, have decreased body levels of vitamin D; this might partly explain their increased risk of cardiovascular disease.Keywords
This publication has 32 references indexed in Scilit:
- Myocardial Infarction is Inversely Associated with Plasma 25-Hydroxyvitamin D3 Levels: A Community-Based StudyInternational Journal of Epidemiology, 1990
- SERUM 25-HYDROXYVITAMIN D AND COLON CANCER: EIGHT-YEAR PROSPECTIVE STUDYThe Lancet, 1989
- Reduction of Blood Pressure by Treatment with AlphacalcidolActa Medica Scandinavica, 1988
- Physical Activity and the Incidence of Coronary Heart DiseaseAnnual Review of Public Health, 1987
- Blood Pressure is Lowered by Vitamin D (Alphacalcidol) during Long‐Term Treatment of Patients with Intermittent HypercalcaemiaActa Medica Scandinavica, 1987
- Treatment with One‐alpha‐hydroxycholecalciferol in Middle‐aged Men with Impaired Glucose Tolerance—A Prospective Randomized Double‐blind StudyActa Medica Scandinavica, 1987
- Evidence for alteration of the vitamin D-endocrine system in obese subjects.Journal of Clinical Investigation, 1985
- Vitamin D Intake, Sunlight Exposure and 25-Hydroxyvitamin D Levels in the Elderly during One YearAnnals of Nutrition and Metabolism, 1984
- INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3The Lancet, 1982
- Vitamin D and Ischaemic Heart DiseaseHormone and Metabolic Research, 1978